ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Cancer Control Working New Review Guidelines: President Asks Congress For Cigarette Regulation

August 15, 1975

New NCI Directory

May 19, 1989

Dendreon’s Provenge Approved For Prostate Cancer Treatment

April 30, 2010

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

December 26, 2008

Bernard Fisher Says Mistake Was Not Publishing Sooner

April 22, 1994

NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000

June 26, 1998